SONOVA N
Sonova Holding AG manufactures and sells hearing care solutions through two segments: Hearing Instruments and Cochlear Implants. The Hearing Instruments segment designs, develops, and distributes hearing instruments and related products under various brand names. The company also offers audiological care services and sells its products through independent distributors. The Cochlear Implants segment involves the design, development, and distribution of hearing implants.
Overview
Strengths
- The company has high returns. ROIC (19.00%) is higher than the sector mean (2.97%).
- EV/EBIT (19.41) is lower than the sector mean.
- Price to free cash flow (18.82) is lower than the sector mean.
- Strong EBITDA Margin of 24.55%.
Weaknesses
- With a depreciation Potential of -21.95%, based on our fundamental analysis, it suggests the stock may be overvalued.
Key Financial Data
| Indicator | Value |
|---|
| PER | 22.8 |
| EV/EBITDA | 13.9 |
| Price/Free Cash Flow' | 18.8 |
| ROIC | 19.0% |
| Net Debt/EBITDA |